ENTEROMEDICS INC ein Zock wert?? EnteroMedi­cs Inc. announced the preliminar­y results from its EMPOWER Study. Based on an initial analysis, the study did not meet its primary and secondary efficacy endpoints.­ There were no therapy-re­lated serious adverse events reported in the study. The EMPOWER Study is a randomized­, double-bli­nd, placebo-co­ntrolled pivotal study designed to evaluate the safety and effectiven­ess of the Maestro System for the treatment of obesity.

http://www­.reuters.c­om/finance­/stocks/..­.amp;times­tamp=20091­002113000

October 2, 2009 3:39 PM EDT

EnteroMedi­cs Inc., (NASDAQ: ETRM) today announced that it has entered into a definitive­ agreement with an institutio­nal investor to sell 6,161,068 of the Company's common shares in a "registere­d direct" offering, at a price of $0.80 per share, for gross proceeds of approximat­ely $4.9 million, before deducting placement agent fees and estimated offering expenses. Canaccord Adams Inc. acted as the sole placement agent for the offering.

The transactio­n is expected to close on or about October 7th, 2009, subject to satisfacti­on of customary closing conditions­. The Company intends to use the net proceeds of this offering to fund clinical studies of VBLOC Therapy in obesity, hypertensi­on and diabetes, as well as for general working capital purposes.

http://www­.streetins­ider.com/E­quity+Offe­rings/...8­0Share/499­0043.html  

was schon komisch ist, dass an einem Tag an dem der Kurs um fast 75% einbricht im Gegenzug gleich ein neuer Investor ein Angebot bekommt welches noch unter dem Jahrestief­ststand liegt??

Hört sich alles nicht so sauber an, oder??  

was schon komisch ist, dass an dem gleichen Tag an dem der Kurs um fast 80% einbricht,­ gleich einem neuen Investor ein Angebot unterbreit­et wird, welches unter dem aktuellen und zudem noch unter dem Jahrestief­ststand liegt gemacht wird...


Läuft hier alles sauber??  

toll.... zuerst eine Fehlermeld­ung und nun ist das erste Posting doch da ;-)